Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Trivalent Intranasal Influenza Vaccine (2008-2009 Strains) in Healthy Adults
NCT00677820Phase 4Completed
- Sponsor
- MedImmune
- Start
- Jun 2008
- Primary completion
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza (2 arms), sponsored by MedImmune. Primary endpoint: Number of Subjects Reporting Fever. Started Jun 2008; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00677820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677820.